@article{de1813237a18457c9472224139fc8326,
title = "Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer",
author = "Suzanne Russo and Anker, {Christopher J.} and May Abdel-Wahab and Nilofer Azad and Nancy Bianchi and Prajnan Das and Jadranka Dragovic and Goodman, {Karyn A.} and William Jones and Timothy Kennedy and Rachit Kumar and Percy Lee and Navesh Sharma and William Small and Suh, {W. Warren} and Jabbour, {Salma K.}",
note = "Funding Information: Disclosures: All panelists were required to declare all conflicts of interest for the previous 36 months before initiating work on this document. These complete disclosure forms are retained by the American Radium Society in perpetuity. The American Radium Society Appropriate Use Criteria Steering Committee reviewed these disclosures with the chair of this document and approved participation of the panelists before starting development of this work. Disclosures potentially relevant to the content of this guideline are provided. P.D. receives consulting fees and an honorarium for the Data Safety Monitoring Board of Eisai Medical Research. K.A.G. serves on the Advisory Board for RenovoRx. P.L. receives consulting fees and an honorarium from AstraZeneca, Varian, and ViewRay and a research grant from AstraZeneca. N.S. receives consulting fees and an honorarium from Sirtex Medical. W.S. receives consulting fees and an honorarium from Varian and Carl Zeiss. S.K.J. receives research grants from Merck and Nestle and personal fees from Elekta. Funding Information: The American Radium Society Appropriate Use Criteria Steering Committee; Sue Yom, MD, PhD; Joseph M. Herman, MD, MSc, MSHCM; Andre Konski, MD; Andrea Taylor; Theodore S. Hong, MD; Jennifer L. Pretz, MD; A. William Blackstock, MD; Albert C. Koong, MD; Miguel Rodriguez-Bigas, MD; Charles R. Thomas Jr, MD; and Jennifer Zook, MD. Disclosures: All panelists were required to declare all conflicts of interest for the previous 36 months before initiating work on this document. These complete disclosure forms are retained by the American Radium Society in perpetuity. The American Radium Society Appropriate Use Criteria Steering Committee reviewed these disclosures with the chair of this document and approved participation of the panelists before starting development of this work. Disclosures potentially relevant to the content of this guideline are provided. P.D. receives consulting fees and an honorarium for the Data Safety Monitoring Board of Eisai Medical Research. K.A.G. serves on the Advisory Board for RenovoRx. P.L. receives consulting fees and an honorarium from AstraZeneca, Varian, and ViewRay and a research grant from AstraZeneca. N.S. receives consulting fees and an honorarium from Sirtex Medical. W.S. receives consulting fees and an honorarium from Varian and Carl Zeiss. S.K.J. receives research grants from Merck and Nestle and personal fees from Elekta.",
year = "2019",
month = nov,
day = "1",
doi = "10.1016/j.ijrobp.2019.06.2544",
language = "English (US)",
volume = "105",
pages = "591--605",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",
}
